IV.5.
The behaviour of radionuclides inhaled by workers is described in Ref. [133] in a human respiratory tract model. Guidance on the use of the human respiratory tract model can be found in Ref. [206].
IV.6.
The human respiratory tract model treats deposition and clearance of inhaled radionuclides separately. It calculates doses to specific tissues of the respiratory tract and takes account of differences in the radiosensitivity of tissues.
IV.7.
The human respiratory tract is represented as two tissues: the extrathoracic airways and the thoracic airways. The extrathoracic airways are divided into two regions, one corresponding to the anterior nasal passage and the other corresponding to the posterior nasal passage, the pharynx and the larynx. The thoracic regions are bronchial, bronchiolar and alveolar–interstitial, the gas exchange region. Lymphatic tissue is associated with both the extrathoracic airways and the thoracic airways. Reference values of dimensions and scaling factors are specified in the model.
IV.8.
Deposition of inhaled particulates is calculated for each region of the respiratory tract, with account taken of both inhalation and exhalation. This is done as a function of particle size, breathing parameters or workload, and is assumed to be independent of chemical form. Age dependent default deposition parameters are given for a range of particle sizes from an activity median aerodynamic diameter (AMAD) of 0.6 nm to 100 μm.
IV.9.
For inhalation of radionuclides by workers, the reference subjects are taken to be normal nose breathing persons undertaking light work. For simplicity, deposition in, and clearance from, the respiratory tract are calculated for the reference adult male only. An AMAD of 5 μm is considered to be the most appropriate default particle size for radionuclides in the workplace [135], whereas an AMAD of 1 μm is used as a default for members of the public.
IV.10.
Clearance from the respiratory tract is treated as two competing processes: particle transport (by mucociliary clearance or translocation to lymph nodes); and absorption to blood. Most of the deposited material that is not absorbed to blood is cleared to the gastrointestinal tract by particle transport. The small amounts transferred to lymph nodes continue to be absorbed into body fluids at the same rate as in the respiratory tract.
IV.11.
The human respiratory tract model assigns gases and vapours to three default solubility and reactivity classes, on the basis of the initial pattern of deposition in the respiratory tract. Subsequent retention in the respiratory tract and absorption to body fluids are determined by the chemical properties of the gas or vapour.
IV.12.
The human respiratory tract model has been used to calculate the dose coefficients for inhalation of radionuclides by workers that were presented in Ref. [130] and table III.2A of GSR Part 3 [2], and also to calculate the bioassay functions presented in Ref. [13].
IV.13.
The ICRP has recently developed a revised version of the human respiratory tract model [16]. The revised version has some simplifications and modifications both to the structure of the model and to the values of its parameters, but the basic features of the model remain unchanged. The modifications are based mainly on experience gained in the application of the model and on new evaluations of the available sets of experimental data. New dose coefficients and bioassay functions for workers, based on this updated model, are given in Ref. [16].